about
Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus.Role of cyclic nucleotide-gated channels in the modulation of mouse hippocampal neurogenesisSynaptic therapy in Alzheimer's disease: a CREB-centric approach.The keystone of Alzheimer pathogenesis might be sought in Aβ physiologyRodent models for Alzheimer's disease drug discovery.Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease.Amyloid-β peptide: Dr. Jekyll or Mr. Hyde?Role of phosphodiesterase 5 in synaptic plasticity and memoryAmyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory.The role of Gpi-anchored axonal glycoproteins in neural development and neurological disorders.Role of the adhesion molecule F3/Contactin in synaptic plasticity and memory.CL316,243, a β3-adrenergic receptor agonist, induces muscle hypertrophy and increased strength.Physiological and pathological processes of synaptic plasticity and memory in drug discovery: Do not forget the dose-response curve.Salidroside, a Bioactive Compound of Rhodiola Rosea, Ameliorates Memory and Emotional Behavior in Adult Mice.A GluR1-cGKII interaction regulates AMPA receptor trafficking.RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice.A key role for TGF-β1 in hippocampal synaptic plasticity and memory.Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease.Time-dependent reversal of synaptic plasticity induced by physiological concentrations of oligomeric Aβ42: an early index of Alzheimer's disease.LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent.Endogenous amyloid-β is necessary for hippocampal synaptic plasticity and memory.Role of F3/contactin expression profile in synaptic plasticity and memory in aged mice.Intracellular accumulation of amyloid-β (Aβ) protein plays a major role in Aβ-induced alterations of glutamatergic synaptic transmission and plasticity.Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory.Improved long-term memory via enhancing cGMP-PKG signaling requires cAMP-PKA signaling.Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory.F3/Contactin promotes hippocampal neurogenesis, synaptic plasticity, and memory in adult mice.Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model.Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.A role for cGMP-dependent protein kinase II in AMPA receptor trafficking and synaptic plasticity.The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice.Object memory enhancement by combining sub-efficacious doses of specific phosphodiesterase inhibitors.Fibrillar beta-amyloid impairs the late phase of long term potentiation.Effect of phosphodiesterase-5 inhibition on apoptosis and beta amyloid load in aged mice.A novel mechanism for cyclic adenosine monophosphate-mediated memory formation: Role of amyloid beta.Hormetic effect of amyloid-β peptide in synaptic plasticity and memory.Role of Amyloid-β and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid CascadeSub-efficacious doses of phosphodiesterase 4 and 5 inhibitors improve memory in a mouse model of Alzheimer's diseaseThe effect of amyloid-β peptide on synaptic plasticity and memory is influenced by different isoforms, concentrations, and aggregation status
P50
Q26858963-13037D8C-285D-4A8B-9E8D-FB55A579FD0EQ28592777-1E3B7A84-EAA3-4497-87FC-2EAC698B3A67Q31133608-131BCA45-50D0-4D3C-9688-8C0366BC1657Q35064948-AAE48848-8D87-4F99-B9E3-B73B3CAD8045Q36113757-62FC1513-33D9-4F33-B836-67B0DD2A9ACBQ36117249-97DF25AB-4D3E-40E2-9DC5-098DC681D399Q36688776-2AC950CA-F4D1-4300-9AAC-0128C5E7ED93Q36966660-1B9BD064-B225-4700-9C19-A369C1EB9EF3Q37252748-B0440654-4F39-4151-B8B6-52A12EBE5FD1Q38720261-39660DAC-365B-44F1-8465-890059804B6CQ39015900-98CE56FD-7E72-4CFA-892C-0AB8719E3CD4Q39049667-EB8C71E2-3343-4601-9920-86218C786CCDQ39164458-9B71BF20-AFD4-4B50-80C7-199D6E24FD2DQ39348440-32D840B2-1618-4997-A8E6-CB11DDA9AD93Q39929101-50F1024B-6ED5-4C81-83FF-F197DFBFE5EAQ40046571-4734CB1F-4840-4FB2-BF20-6F6CFDC07CB6Q40251711-283532E0-6FB2-4129-A20C-4DB091AE66BBQ40852368-4F64CF00-15B5-49C3-B02B-AC274F6F5BE6Q40961591-EA273262-EF07-42D5-9CF5-25343B8956B1Q40991050-E6658E41-A553-4AD8-BAAF-D9AAEFCB0A97Q41138294-86D8EFAD-0D6D-41E9-ADD9-26D2A01140F3Q41210086-FC23E31C-F65F-4A3F-A423-FC5C35B924EBQ41467629-B3C81484-8604-470A-BD2C-F9A1591D4280Q42465835-F36126A0-C5BA-4E39-980F-5E53E9E4DAF4Q42693894-E76CC529-3555-45AE-AAFE-2CF4E3DDBE65Q42958032-F77492C6-10AB-4C40-A656-9FDA9488694AQ44855089-A11E00E5-87F2-495D-9AFE-5A24F7A0D44BQ45902205-29F980A6-5DD9-4D49-B9BB-3FDEB7F76A25Q45954200-CA28D0B8-9BDD-48A8-BD22-775C31E3840BQ46610687-4E07D676-64FC-424D-962A-FCC01FF8C6B8Q47123185-5DDEFC50-79DE-4C6E-83CB-161CD3931558Q47883840-3D38255E-87C5-4169-ADE4-80E0F2A00348Q48218737-6B8B060D-A776-4606-86DB-584A50C4F013Q48471683-28CCDCD9-16E2-4452-97A6-46C9B678356AQ48943752-2E425111-DF0F-44AC-A327-EB526C394FA3Q50683246-9C2AE62A-AD39-4823-AFC3-D9F02CE6630AQ50970941-0AA5892E-212E-43E7-802D-E55644FCFC36Q58202799-5813DE58-B9E6-4E4B-9384-8CA898D5C3F1Q58202800-629E3A71-023C-4EC4-9824-1F025F860E1FQ58202802-C7895177-D220-46DC-A590-3A4B7A326682
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniela Puzzo
@ast
Daniela Puzzo
@en
Daniela Puzzo
@es
Daniela Puzzo
@nl
type
label
Daniela Puzzo
@ast
Daniela Puzzo
@en
Daniela Puzzo
@es
Daniela Puzzo
@nl
prefLabel
Daniela Puzzo
@ast
Daniela Puzzo
@en
Daniela Puzzo
@es
Daniela Puzzo
@nl
P106
P21
P31
P496
0000-0002-9542-2251